Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018
Diagnostic Kits / Equipment		2.01B	2.05B	3.98B	1.18B	999.01M
Diagnostic Kits / Equipment Growth		-2.02%	-48.42%	237.95%	17.91%	13.87%
Total		2.01B	2.05B	3.98B	1.18B	999.01M
Total Growth		-2.02%	-48.42%	237.95%	17.91%	13.87%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018
China		1.72B	1.85B	-	-	-
China Growth		-7.03%	-	-	-	-
Overseas		250.03M	164.41M	-	-	205.88M
Overseas Growth		52.08%	-	-	-	397.23%
South China		-	-	-	-	444.17M
South China Growth		-	-	-	-	-15.93%
East China		-	-	-	-	153.15M
East China Growth		-	-	-	-	1.10%
Central China		-	-	-	-	57.91M
Central China Growth		-	-	-	-	21.28%
Northern Region		-	-	-	-	42.69M
Northern Region Growth		-	-	-	-	54.88%
Southwest Region		-	-	-	-	25.20M
Southwest Region Growth		-	-	-	-	3.90%
Northwest District		-	-	-	-	19.59M
Northwest District Growth		-	-	-	-	4.00%
Northeast Region		-	-	-	-	14.42M
Northeast Region Growth		-	-	-	-	-37.17%
Total		1.97B	2.02B	-	-	963.01M
Total Growth		-2.22%	-	-	-	11.64%

Source: S&P Global Market Intelligence.